LabMed Discovery2025，Vol.2Issue(2)：P.57-66,10.DOI:10.1016/j.lmd.2025.100074
Clinical potential of undercarboxylated osteocalcin in metabolic and neurodegenerative diseases:From biomarker to therapeutic target
Ying-ying Ding 1Yu-ying Yang 1Li-hao Sun 1Jian-min Liu 1Bei Tao1
作者信息
- 1. Department of Endocrine and Metabolic Diseases,Shanghai Institute of Endocrine and Metabolic Diseases,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China Shanghai National Clinical Research Center for Metabolic Diseases,Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of China,Shanghai National Center for Translational Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
- 折叠
摘要
关键词
Osteocalcin(OCN)/Nonalcoholic fatty liver disease(NAFLD)/Diabetes mellitus(DM)/Osteoporosis(OP)/Atherosclerosis/Neurodegenerative diseases(NDs)分类
医药卫生引用本文复制引用
Ying-ying Ding,Yu-ying Yang,Li-hao Sun,Jian-min Liu,Bei Tao..Clinical potential of undercarboxylated osteocalcin in metabolic and neurodegenerative diseases:From biomarker to therapeutic target[J].LabMed Discovery,2025,2(2):P.57-66,10.
